Elevance Health Inc. (0HG8.L)
USD 408.81
(-1.12%)
USD 408.81
(-1.12%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 18.59 Billion USD | 11.16% |
| 2022 | 16.72 Billion USD | -7.85% |
| 2021 | 18.15 Billion USD | 26.98% |
| 2020 | 14.29 Billion USD | -5.64% |
| 2019 | 15.14 Billion USD | -0.84% |
| 2018 | 15.27 Billion USD | -6.41% |
| 2017 | 16.32 Billion USD | 40.09% |
| 2016 | 11.65 Billion USD | -15.27% |
| 2015 | 13.75 Billion USD | 5.77% |
| 2014 | 13 Billion USD | 0.7% |
| 2013 | 12.9 Billion USD | 3.33% |
| 2012 | 12.49 Billion USD | 64.52% |
| 2011 | 7.59 Billion USD | 5.99% |
| 2010 | 7.16 Billion USD | 99.97% |
| 2009 | 3.58 Billion USD | -46.18% |
| 2008 | 6.65 Billion USD | 6.08% |
| 2007 | 6.27 Billion USD | 42.25% |
| 2006 | 4.41 Billion USD | 8.52% |
| 2005 | 4.06 Billion USD | 44.2% |
| 2004 | 2.81 Billion USD | 76.22% |
| 2003 | 1.6 Billion USD | 20.99% |
| 2002 | 1.32 Billion USD | 83.08% |
| 2001 | 722.3 Million USD | 20.89% |
| 2000 | 597.5 Million USD | 14.46% |
| 1999 | 522 Million USD | 72.9% |
| 1998 | 301.9 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 19.28 Billion USD | -9.0% |
| 2024 Q1 | 20.22 Billion USD | 8.77% |
| 2024 Q2 | 21.18 Billion USD | 4.77% |
| 2023 FY | 18.59 Billion USD | 11.16% |
| 2023 Q3 | 13.92 Billion USD | -7.98% |
| 2023 Q4 | 18.59 Billion USD | 33.53% |
| 2023 Q1 | 15.32 Billion USD | -8.39% |
| 2023 Q2 | 15.13 Billion USD | -1.25% |
| 2022 Q2 | 17.13 Billion USD | 0.22% |
| 2022 Q4 | 16.72 Billion USD | 12.26% |
| 2022 FY | 16.72 Billion USD | -7.85% |
| 2022 Q1 | 17.09 Billion USD | -5.82% |
| 2022 Q3 | 14.9 Billion USD | -13.03% |
| 2021 Q2 | 17.98 Billion USD | 29.3% |
| 2021 FY | 18.15 Billion USD | 26.98% |
| 2021 Q3 | 17.29 Billion USD | -3.83% |
| 2021 Q4 | 18.15 Billion USD | 4.95% |
| 2021 Q1 | 13.9 Billion USD | -2.7% |
| 2020 Q1 | 16.33 Billion USD | 7.86% |
| 2020 FY | 14.29 Billion USD | -5.64% |
| 2020 Q4 | 14.29 Billion USD | -15.21% |
| 2020 Q3 | 16.85 Billion USD | 9.13% |
| 2020 Q2 | 15.44 Billion USD | -5.45% |
| 2019 FY | 15.14 Billion USD | -0.84% |
| 2019 Q3 | 16.04 Billion USD | 5.4% |
| 2019 Q4 | 15.14 Billion USD | -5.56% |
| 2019 Q1 | 14.86 Billion USD | -2.73% |
| 2019 Q2 | 15.21 Billion USD | 2.41% |
| 2018 Q3 | 15.15 Billion USD | 3.8% |
| 2018 FY | 15.27 Billion USD | -6.41% |
| 2018 Q2 | 14.6 Billion USD | -4.27% |
| 2018 Q4 | 15.27 Billion USD | 0.78% |
| 2018 Q1 | 15.25 Billion USD | -6.54% |
| 2017 Q2 | 11.73 Billion USD | 13.12% |
| 2017 FY | 16.32 Billion USD | 40.09% |
| 2017 Q4 | 16.32 Billion USD | 61.08% |
| 2017 Q3 | 10.13 Billion USD | -13.62% |
| 2017 Q1 | 10.37 Billion USD | -11.0% |
| 2016 Q3 | 13.06 Billion USD | -6.6% |
| 2016 FY | 11.65 Billion USD | -15.27% |
| 2016 Q2 | 13.98 Billion USD | -0.99% |
| 2016 Q1 | 14.12 Billion USD | 2.74% |
| 2016 Q4 | 11.65 Billion USD | -10.81% |
| 2015 Q1 | 14.44 Billion USD | 11.09% |
| 2015 Q2 | 15.08 Billion USD | 4.42% |
| 2015 Q3 | 14.71 Billion USD | -2.44% |
| 2015 Q4 | 13.75 Billion USD | -6.53% |
| 2015 FY | 13.75 Billion USD | 5.77% |
| 2014 Q4 | 13 Billion USD | -4.02% |
| 2014 Q3 | 13.54 Billion USD | 4.09% |
| 2014 Q1 | 13.06 Billion USD | 1.24% |
| 2014 Q2 | 13.01 Billion USD | -0.44% |
| 2014 FY | 13 Billion USD | 0.7% |
| 2013 Q4 | 12.9 Billion USD | 1.82% |
| 2013 FY | 12.9 Billion USD | 3.33% |
| 2013 Q2 | 13.49 Billion USD | 2.9% |
| 2013 Q1 | 13.11 Billion USD | 4.97% |
| 2013 Q3 | 12.67 Billion USD | -6.04% |
| 2012 Q3 | 11.14 Billion USD | 21.2% |
| 2012 Q1 | 7.19 Billion USD | -5.26% |
| 2012 Q4 | 12.49 Billion USD | 12.09% |
| 2012 FY | 12.49 Billion USD | 64.52% |
| 2012 Q2 | 9.19 Billion USD | 27.83% |
| 2011 FY | 7.59 Billion USD | 5.99% |
| 2011 Q4 | 7.59 Billion USD | 1.41% |
| 2011 Q1 | 6.59 Billion USD | -7.9% |
| 2011 Q2 | 7.14 Billion USD | 8.33% |
| 2011 Q3 | 7.48 Billion USD | 4.75% |
| 2010 Q1 | 4.86 Billion USD | 35.75% |
| 2010 FY | 7.16 Billion USD | 99.97% |
| 2010 Q2 | 6.52 Billion USD | 34.06% |
| 2010 Q4 | 7.16 Billion USD | 5.72% |
| 2010 Q3 | 6.77 Billion USD | 3.94% |
| 2009 Q2 | 7.44 Billion USD | 7.01% |
| 2009 Q3 | 7.02 Billion USD | -5.74% |
| 2009 Q4 | 3.58 Billion USD | -48.96% |
| 2009 FY | 3.58 Billion USD | -46.18% |
| 2009 Q1 | 6.95 Billion USD | 4.53% |
| 2008 Q4 | 6.65 Billion USD | -4.13% |
| 2008 Q1 | 6.73 Billion USD | 7.3% |
| 2008 Q2 | 7.49 Billion USD | 11.3% |
| 2008 FY | 6.65 Billion USD | 6.08% |
| 2008 Q3 | 6.94 Billion USD | -7.35% |
| 2007 Q3 | 5.87 Billion USD | 48.18% |
| 2007 Q4 | 6.27 Billion USD | 6.76% |
| 2007 FY | 6.27 Billion USD | 42.25% |
| 2007 Q2 | 3.96 Billion USD | 7.09% |
| 2007 Q1 | 3.7 Billion USD | -16.04% |
| 2006 Q3 | 5.11 Billion USD | -7.59% |
| 2006 FY | 4.41 Billion USD | 8.52% |
| 2006 Q4 | 4.41 Billion USD | -13.73% |
| 2006 Q2 | 5.53 Billion USD | 10.69% |
| 2006 Q1 | 5 Billion USD | 22.98% |
| 2005 Q1 | 2.78 Billion USD | -1.32% |
| 2005 Q2 | 2.66 Billion USD | -4.06% |
| 2005 Q3 | 2.21 Billion USD | -17.04% |
| 2005 FY | 4.06 Billion USD | 44.2% |
| 2005 Q4 | 4.06 Billion USD | 83.6% |
| 2004 Q4 | 2.81 Billion USD | 137.25% |
| 2004 Q3 | 1.18 Billion USD | 18.51% |
| 2004 Q2 | 1 Billion USD | -27.65% |
| 2004 FY | 2.81 Billion USD | 76.22% |
| 2004 Q1 | 1.38 Billion USD | -13.38% |
| 2003 Q2 | 1.56 Billion USD | -1.18% |
| 2003 Q3 | 1.43 Billion USD | -7.84% |
| 2003 Q4 | 1.6 Billion USD | 11.17% |
| 2003 FY | 1.6 Billion USD | 20.99% |
| 2003 Q1 | 1.58 Billion USD | 19.5% |
| 2002 Q3 | 1.11 Billion USD | 143.88% |
| 2002 FY | 1.32 Billion USD | 83.08% |
| 2002 Q4 | 1.32 Billion USD | 18.31% |
| 2002 Q1 | 722.6 Million USD | 0.04% |
| 2002 Q2 | 458.3 Million USD | -36.58% |
| 2001 FY | 722.3 Million USD | 20.89% |
| 2001 Q4 | 722.3 Million USD | 43.83% |
| 2001 Q3 | 502.2 Million USD | 0.0% |
| 2000 FY | 597.5 Million USD | 14.46% |
| 1999 FY | 522 Million USD | 72.9% |
| 1998 FY | 301.9 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 24715.751% |
| Accuray Incorporated | 103.58 Million USD | -17850.302% |
| Align Technology, Inc. | -840.47 Million USD | 2312.334% |
| AxoGen, Inc. | 32.26 Million USD | -57527.224% |
| Boston Scientific Corporation | 8.23 Billion USD | -125.875% |
| CVS Health Corporation | 71.18 Billion USD | 73.881% |
| Cardinal Health, Inc. | 476 Million USD | -3806.303% |
| Centene Corporation | 506 Million USD | -3574.704% |
| DaVita Inc. | 10.65 Billion USD | -74.562% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 54.565% |
| Hologic, Inc. | 374.4 Million USD | -4866.346% |
| Humana Inc. | 5.51 Billion USD | -236.909% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -3664.364% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | -243.227% |
| Masimo Corporation | 804 Million USD | -2212.687% |
| McKesson Corporation | 889 Million USD | -1991.564% |
| Patterson Companies, Inc. | 648.47 Million USD | -2767.329% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | -297.053% |
| ResMed Inc. | 635.57 Million USD | -2825.544% |
| Henry Schein, Inc. | 2.57 Billion USD | -623.502% |
| Teladoc Health, Inc. | 468.6 Million USD | -3867.973% |
| Universal Health Services, Inc. | 5.24 Billion USD | -254.361% |
| Veeva Systems Inc. | -647.71 Million USD | 2970.72% |
| Baxter International Inc. | 11.16 Billion USD | -66.523% |
| Becton, Dickinson and Company | 14.46 Billion USD | -28.563% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 798.944% |
| Danaher Corporation | 13.49 Billion USD | -37.815% |
| Stryker Corporation | 10.02 Billion USD | -85.495% |
| Medtronic plc | 23.67 Billion USD | 21.475% |